Complete Story
02/16/2022
AMDA - The Society for PALTC Medicine | February 16
COMMERCIAL: COVID-19 Update
Headlines:
Journal Articles/Preprints
- Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- JAMDA: Reference Ranges for Gait Speed and Sit-to-Stand Performance in a Cohort of Mobility-Intact Community-Dwelling Older Adults From Singapore
- JAMDA: Potential Unintended Consequences of Antipsychotic Reduction in Ontario Nursing Homes
- Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium
- Slowing gait speed precedes cognitive decline by several years
Research Reports/White Papers
- High-risk antibiotic use common in nursing homes after hospitalization
- COVID-19 takes serious toll on heart health—a full year after recovery
- Study shows life-saving benefit of baricitinib for ventilated COVID patients
Podcasts/Webinars
News/News Analysis
- CMS warns states: Survey fully or suffer consequences
- FDA OKs New Monoclonal Antibody to Treat Omicron — Bebtelovimab has also shown activity against BA.2 subvariant, agency says
- Eagerly awaited COVID lifesavers molnupiravir, Paxlovid now wait for patients
- Workforce advisory council offers direct care workers voice in recruitment, retention efforts
- Transforming direct care workforce requires innovative strategies, policy changes: study
- United States Files False Claims Act Lawsuit Against Tuscaloosa Psychiatrist for Improper Prescribing of Nuedexta to Nursing Home Residents
- In a victory for pain experts, CDC tones down its opioid prescribing guidelines
- Should You Get a POLST? These portable medical orders give the seriously ill more control over their care
- CMS, CDC officials: Increase in falls, pressure injuries demands renewed safety focus
- SNFs Battle for Post-Acute Market Share as Competitors Rise